Pharmaceuticals, Biotechnology & Life Sciences Logo
Intarcia Therapeutics Company Logo

Working At Intarcia Therapeutics

Zippia Score 4.1

Intarcia Therapeutics overview

Based in Boston, Massachusetts, Intarcia Therapeutics is a medium-sized technology company with 340 employees and a revenue of $75.0M.
Founded in 1995, Intarcia Therapeutics is an established company that loves to hire graduates from University of California - Santa Barbara, with 8.0% of its employees having attended University of California - Santa Barbara. Want to compare Intarcia Therapeutics to some other great places to work in Boston, Massachusetts? We suggest taking a look at Zippia's list of Best Companies to Work For in Boston, Massachusetts. The average employee at Intarcia Therapeutics makes $71,474 per year. Pay at Intarcia Therapeutics is significantly lower than some of its highest paying competitors, like T2 Biosystems, ARROWEYE SOLUTIONS, and SAAMA TECH, which pay $93,022, $89,417, and $88,330, respectively.
Intarcia Therapeutics is dedicated to redesigning the treatment of chronic disease. We are rethinking the future of medicine with people at the center of the experience.

Industry

Biotechnology

Revenue

$75.0M

Employees

340

Founded in

1995

Headquarters

Boston, MA

Website

intarcia.com

Website

intarcia.com

Organization Type

Private

Is This Your Company?

The team at Intarcia Therapeutics

Key People
  • Jay Skyler (Director)
  • Alice Leung (President)
  • Jim Rosenthal (Director)
  • Raymond Keane (Executive Officer)
  • Thomas Alessi (Executive Officer)
  • Paul Feldman (Executive Officer)
  • Nancy Thornberry (Director)
  • Bryan Roberts (Director)
  • Bob Kerrey (Director)
  • Thane Wettig (Executive Officer)
  • Fred Fiedorek (Executive Officer)
  • Jay Smith (Executive Officer)
  • Anthony Hurley (Executive Officer)
  • Gino Santini (Director)
  • James Ahlers (Executive Officer)
  • Patrick Conway (Director)
  • Kurt Graves (Chairman, President, CEO)
The Inside Scoop
Intarcia Therapeutics is dedicated to redesigning the treatment of chronic disease. We are rethinking the future of medicine with people at the center of the experience.

What do people say about Intarcia Therapeutics

Do you work at Intarcia Therapeutics ? Anonymously review Intarcia Therapeutics as an Employer.

What Do You Like About Working For Intarcia Therapeutics?

Intarcia Therapeutics Rankings

Intarcia Therapeutics is ranked #50 on the Best Technology Companies to Work For in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Intarcia Therapeutics careers

On average, employees at Intarcia Therapeutics stay with the company for 1.2 years.

Average Length of Employment
Theranos1.9 years
T2 Biosystems1.3 years

Intarcia Therapeutics

1.2 years
00

Do you Work At Intarcia Therapeutics?

Help us make this company more transparent.

Intarcia Therapeutics Financial Performance

8.2
Performance Score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

Revenue

$10M - $100M

Founded in

1995

Organization type

Private

Intarcia Therapeutics Financing Rounds

DateAmount
Mar 12, 2019Debt
$150,000,000
Aug 4, 2017Equity
$850,000,020
Jan 13, 2017Equity
$3,594
Jan 6, 2017Equity
$650,000,040
Apr 7, 2014Equity
$200,000,023
Nov 29, 2012Equity
$160,000,000
Aug 30, 2012Debt
$47,523,114
Aug 25, 2011Debt
$43,962,606
Sep 7, 2010Debt
$15,000,000
May 14, 2010Equity
$16,000,000

How Would You Rate The Company Culture Of Intarcia Therapeutics?

Have you worked at Intarcia Therapeutics? Help other job seekers by rating Intarcia Therapeutics.

Intarcia Therapeutics Competitors

Company
T2 BiosystemsBiotechnology

Avg: $93,022

ARROWEYE SOLUTIONSTechnology Hardware, Storage and Peripherals

Avg: $89,417

SAAMA TECHSoftware

Avg: $88,330

TRACKABOUTSoftware

Avg: $88,082

GRIDPOINTSoftware

Avg: $87,421

Frequently Asked Questions about Intarcia Therapeutics

When was Intarcia Therapeutics founded?

Intarcia Therapeutics was founded in 1995.

How many Employees does Intarcia Therapeutics have?

Intarcia Therapeutics has 340 employees.

How much money does Intarcia Therapeutics make?

Intarcia Therapeutics generates $75.0M in revenue.

What industry is Intarcia Therapeutics in?

Intarcia Therapeutics is in the biotechnology industry.

What type of company is Intarcia Therapeutics?

Intarcia Therapeutics is a private company.

Who are Intarcia Therapeutics's competitors?

Intarcia Therapeutics competitors include T2 Biosystems, Theranos, UNTANGLE, TRACKABOUT, SAJAN CONSULTING, PIVOT3, SANPULSE TECH, Ikasystems Corp, ARROWEYE SOLUTIONS, QBE, GRIDPOINT, REGENT EDUCATION, Roqa, Silkroad, Inc., SAAMA TECH, MBA FOCUS, Accertify, CELLERANT THERAPEUTICS, VISAGE MOBILE, RBM TECH.

Who works at Intarcia Therapeutics?

Jay Skyler (Director)

Alice Leung (President)

Jim Rosenthal (Director)

Show More

Where is Intarcia Therapeutics's headquarters?

Intarcia Therapeutics's headquarters is in Boston, MA.

Are you an executive, HR leader, or brand manager at Intarcia Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

You can find out what it is like to work at Intarcia Therapeutics, also known as INTARCIA THERAPEUTICS INC, INTARCIA THERAPEUTICS, INC, Intarcia Therapeutics and Intarcia Therapeutics, Inc..

Zippia gives an in-depth look into the details of Intarcia Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Intarcia Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Intarcia Therapeutics. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions, or for the results obtained from the use of this information. The data presented on this page does not represent the view of Intarcia Therapeutics and its employees or that of Zippia.